APA (7th ed.) Citation

Yang G, Sun S, Wang J, Li W, Wang X, Yuan L, & Li S. (2020). S-Allylmercaptocysteine Targets Nrf2 in Osteoarthritis Treatment Through NOX4/NF-κB Pathway. Dove Medical Press.

Chicago Style (17th ed.) Citation

Yang G, Sun S, Wang J, Li W, Wang X, Yuan L, and Li S. S-Allylmercaptocysteine Targets Nrf2 in Osteoarthritis Treatment Through NOX4/NF-κB Pathway. Dove Medical Press, 2020.

MLA (9th ed.) Citation

Yang G, et al. S-Allylmercaptocysteine Targets Nrf2 in Osteoarthritis Treatment Through NOX4/NF-κB Pathway. Dove Medical Press, 2020.